Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20011130 | 0.79 | TSHR (0.41) | L3MBTL1CYP1A2LMNACHRM2ADRA2A | |
| SCHEMBL20429744 | 0.78 | LMNA (0.33) | LMNACHRM2ADRA2ACYP2D6TSHR | |
| SCHEMBL18355718 | 0.76 | LMNA (0.46) | LMNACHRM2ADRA2ACYP2D6TSHR | |
| SCHEMBL22770864 | 0.76 | — | — | |
| SCHEMBL15987057 | 0.75 | ATM (0.33) | ATML3MBTL1 | |
| SCHEMBL3062964 | 0.74 | LMNA (0.45) | ATMLMNACHRM2ADRA2ACYP2D6 | |
| Hydrochloric Acid SCHEMBL4563303 | 0.72 | MAPT (0.46) | ATMLMNACHRM2ADRA2ACYP2D6 | |
| SCHEMBL16512349 | 0.72 | CHRNA7 (0.38) | LMNACHRM2ADRA2ACYP2D6TSHR | |
| SCHEMBL16512320 | 0.72 | CHRNA7 (0.38) | LMNACHRM2ADRA2ACYP2D6TSHR | |
| SCHEMBL15987053 | 0.72 | CRBN (0.31) | ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119855818-A | Compound and application thereof in treatment of chronic hepatitis B, hepatic fibrosis and liver cancer | 河北乌图药业有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2024217429-A1 | COMPOUND AND USE THEREOF IN TREATMENT OF CHRONIC HEPATITIS B, HEPATIC FIBROSIS AND LIVER CANCER | 河北乌图药业有限公司 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024217452-A1 | COMPOUND AND USE THEREOF IN TREATMENT OF CHRONIC HEPATITIS B, LIVER FIBROSIS, AND LIVER CANCER | 河北乌图药业有限公司 | 2024-10-24 | — | — | WO | disclosed |